secwatch / observer
8-K filed April 3, 2023, 7:59 PM ET ticker VAL CIK 0000314808
debt confidence high sentiment neutral materiality 0.75

Valaris announces $600M private placement of senior secured second lien notes due 2030 to redeem $550M first lien notes

Valaris Ltd

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Valaris Ltd entered into Credit Agreement with lenders from time to time party thereto, Citibank, N.A., as Administrative Agent, Wilmington Savings Fund Society, FSB, as Collateral Trustee, the issuing banks from time to time party thereto and Citibank, N.A., Deutsche Bank Securities Inc. and DNB Markets, Inc., as Joint Lead Arrangers and Lead B valued at $375 million (effective 2023-04-03).

Action
entry
Agreement
credit facility
Counterparty
lenders from time to time party thereto, Citibank, N.A., as Administrative Agent, Wilmington Savings Fund Society, FSB, as Collateral Trustee, the issuing banks from time to time party thereto and Citibank, N.A., Deutsche Bank Securities Inc. and DNB Markets, Inc., as Joint Lead Arrangers and Lead B
Value
$375 million
Effective
2023-04-03
Exact text from the filing
On April 3, 2023, Valaris Limited (the “Company”) entered into a senior secured revolving credit facility (the “Revolving Credit Facility”) with the lenders from time to time party thereto, Citibank, N.A., as Administrative Agent, Wilmington Savings Fund Society, FSB, as Collateral Trustee, the issuing banks from time to time party thereto and Citibank, N.A., Deutsche Bank Securities Inc. and DNB Markets, Inc., as Joint Lead Arrangers and Lead Bookrunners.
View on SEC.gov

Browse all material agreements →

Valaris Ltd filing history →

Source: SEC EDGAR
accession 0001104659-23-040702
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.